Niacin (as Inositol Hexanicotinate)
Mechanism of Action +
### Chemical Structure and Pharmacokinetics
Inositol hexanicotinate (IHN), also referred to as inositol nicotinate, is a synthetic compound created by esterifying six molecules of nicotinic acid (niacin) to a single molecule of meso-inositol. This hexanicotinic acid ester is designed to act as a slow-release delivery system for vitamin B3. Pharmacokinetic studies reveal that approximately 70% of an orally ingested dose of IHN is absorbed intact through the gastrointestinal mucosa into the bloodstream.
Once in systemic circulation, IHN is subjected to enzymatic hydrolysis by esterases, which slowly cleave the ester bonds to liberate free nicotinic acid and inositol. The rate of this hydrolysis is exceptionally slow. Clinical measurements demonstrate that oral administration of IHN results in a steady, prolonged increase in free nicotinic acid levels, with serum concentrations peaking roughly 6 to 10 hours post-ingestion. This is in stark contrast to immediate-release free nicotinic acid, which reaches peak plasma levels in merely 30 minutes. Furthermore, the absolute bioavailability of free niacin from IHN is remarkably low; a 1,000 mg dose of IHN yields a peak plasma niacin concentration of approximately 0.2 µg/mL, whereas an equivalent 1,000 mg dose of free nicotinic acid produces a peak of 30 µg/mL.
### The HCA2 Receptor and the 'Flush' Mechanism
The profound difference in peak plasma concentrations explains the primary marketing feature of IHN: it is 'flush-free'. The niacin flush—characterized by cutaneous vasodilation, warmth, redness, and itching—is mediated by the activation of the hydroxycarboxylic acid receptor 2 (HCA2, also known as GPR109A). This receptor is highly expressed on epidermal Langerhans cells and macrophages. When free nicotinic acid binds to HCA2, it triggers a signaling cascade that releases arachidonic acid, which is subsequently converted by cyclooxygenase (COX) enzymes into prostaglandins, primarily prostaglandin D2 (PGD2) and prostaglandin E2 (PGE2). These prostaglandins act on DP1 and EP2/EP4 receptors in dermal capillaries, causing profound vasodilation. Because IHN hydrolysis is so slow, the concentration of free nicotinic acid never reaches the threshold required to robustly activate HCA2 on these dermal cells, thereby entirely bypassing the flush response.
### Lipid Metabolism Discrepancies
The same HCA2 receptor responsible for the flush is also expressed on adipocytes (fat cells), where its activation by high-dose nicotinic acid inhibits hormone-sensitive lipase. This inhibition reduces the mobilization of free fatty acids (FFAs) from adipose tissue to the liver, subsequently decreasing the hepatic synthesis of very-low-density lipoprotein (VLDL) and, consequently, low-density lipoprotein (LDL), while raising high-density lipoprotein (HDL). Because IHN fails to deliver a high peak concentration of free nicotinic acid, it fails to sufficiently activate HCA2 on adipocytes. Consequently, clinical evidence overwhelmingly shows that IHN is ineffective at reducing cholesterol or improving lipid profiles, despite being marketed as a niacin supplement.
### Hemorheological and Peripheral Vascular Effects
While IHN lacks lipid-lowering efficacy, it demonstrates unique pharmacological properties related to blood flow and hemorheology. The exact mechanism is not fully elucidated, but it is hypothesized that either the intact IHN molecule or its slow, sustained release of nicotinic acid and inositol exerts direct effects on the vascular endothelium and blood components. IHN has been shown to reduce plasma levels of fibrinogen, a glycoprotein complex essential for blood clot formation. By lowering fibrinogen, IHN decreases whole blood viscosity and improves erythrocyte deformability. This enhances microcirculatory blood flow and oxygen transport to peripheral tissues. These mechanisms underpin the clinical use of IHN (often under the brand name Hexopal) for conditions characterized by peripheral vascular spasms or poor circulation, such as Raynaud's syndrome and intermittent claudication.
### NAD and NADP Biosynthesis
Despite its slow release, the nicotinic acid liberated from IHN is fully bioactive and enters the Preiss-Handler pathway to synthesize nicotinamide adenine dinucleotide (NAD+). NAD+ is a critical coenzyme found in all living cells, required by over 400 enzymes to catalyze metabolic redox reactions. NAD+ acts as an electron carrier in catabolic pathways, facilitating the transfer of potential energy from carbohydrates, fats, and proteins to generate adenosine triphosphate (ATP) during cellular respiration. Additionally, NAD+ is phosphorylated to form nicotinamide adenine dinucleotide phosphate (NADP+), which is essential for anabolic reactions (such as the synthesis of cholesterol and fatty acids) and for maintaining cellular antioxidant defenses by regenerating reduced glutathione. Therefore, IHN successfully fulfills the nutritional requirements of vitamin B3 to prevent deficiency (pellagra) and support baseline cellular energy metabolism.
What is niacin inositol hexanicotinate good for? +
Is inositol hexanicotinate the same as B3? +
Does inositol hexanicotinate lower cholesterol? +
Why is niacin no longer recommended for cholesterol as much? +
What are the side effects of inositol hexanicotinate? +
Is niacin inositol hexanicotinate safe? +
What medications cannot be taken with niacin? +
What medications should not be taken with inositol? +
Will inositol hexanicotinate cause a flush? +
How long does it take for inositol hexanicotinate to work? +
What is the difference between IHN and Niacinamide? +
Can I take IHN on an empty stomach? +
Does IHN contain real inositol? +
Why do supplement companies sell IHN for cholesterol if it doesn't work? +
What is considered a high dose of niacin? +
Everything About Niacin (as Inositol Hexanicotinate) Article
## Introduction to Inositol Hexanicotinate
Vitamin B3, commonly known as niacin, is one of the most critical water-soluble vitamins in the human diet. It is famous for two things: its essential role in cellular energy production and its ability to cause a profound, sometimes uncomfortable, skin 'flush' when taken in high doses. For decades, consumers and formulators have sought ways to reap the benefits of niacin without the fiery red skin reaction. Enter Inositol Hexanicotinate (IHN), widely marketed as 'No-Flush Niacin'.
Inositol hexanicotinate is a unique chemical complex consisting of six molecules of nicotinic acid (niacin) bound to a central molecule of meso-inositol. This structure was specifically designed to act as a slow-release delivery mechanism. By requiring the body to slowly break down the ester bonds to access the niacin, IHN successfully eliminates the flushing side effect. However, this slow release fundamentally changes how the compound behaves in the body, making it highly effective for certain conditions (like peripheral blood flow) but completely ineffective for others (like cholesterol management).
## The Science of 'No-Flush' Niacin
To understand why IHN doesn't cause flushing, we must first understand why standard niacin does. When you consume immediate-release nicotinic acid, it rapidly absorbs into the bloodstream, peaking in about 30 minutes. This massive spike in plasma niacin activates a specific receptor called HCA2 (or GPR109A), which is heavily concentrated on immune cells in the skin. Activation of HCA2 triggers a cascade of prostaglandins (specifically PGD2 and PGE2) that cause the blood vessels in the skin to rapidly dilate, resulting in the red, warm, itchy sensation known as the niacin flush.
Because Inositol Hexanicotinate is a large, complex molecule, it is absorbed intact and must be slowly hydrolyzed (broken down) by enzymes in the liver and blood. This process is incredibly slow. Research shows that serum levels of free nicotinic acid from IHN don't peak until 6 to 10 hours after ingestion. More importantly, the peak concentration is minuscule. A 1,000 mg dose of IHN results in a peak plasma level of just 0.2 µg/mL, compared to a massive 30 µg/mL from the same dose of free niacin. Because the concentration of free niacin never gets high enough to activate the HCA2 receptors in the skin, the flush never occurs.
## The Cholesterol Myth of IHN
One of the most pervasive myths in the supplement industry is that 'No-Flush Niacin' (IHN) can be used as a comfortable alternative to standard niacin for lowering cholesterol. This is definitively false.
The lipid-lowering effects of niacin rely on the exact same HCA2 receptor that causes the flush. When high concentrations of free nicotinic acid activate HCA2 receptors on fat cells (adipocytes), it inhibits the release of free fatty acids. This starves the liver of the raw materials it needs to produce VLDL and LDL cholesterol. Because Inositol Hexanicotinate never achieves high peak plasma levels of free niacin, it completely fails to activate these receptors on fat cells.
Examine.com and multiple clinical reviews explicitly state that IHN is ineffective for reducing cholesterol or inducing the beneficial lipid changes associated with standard nicotinic acid. If your primary goal is cardiovascular disease risk reduction via lipid management, IHN is not the correct supplement.
## Cardiovascular and Hemorheological Benefits
If IHN doesn't lower cholesterol, what is it good for? The answer lies in hemorheology—the study of blood flow properties. While it fails to alter lipids, IHN has demonstrated a unique ability to improve peripheral circulation.
Clinical evidence, including data cited by WebMD and the Natural Medicines Comprehensive Database, shows that IHN (often studied under the European brand name Hexopal) is possibly effective for treating Raynaud's syndrome. Raynaud's is a condition characterized by a painful response to cold, where blood vessels in the fingers and toes spasm and restrict blood flow. IHN appears to help by reducing plasma levels of fibrinogen, a protein involved in blood clotting. By lowering fibrinogen, IHN decreases the overall viscosity (thickness) of the blood, allowing it to flow more easily through tiny capillaries.
Additionally, this improvement in blood viscosity and mild vasodilation has shown promise in treating intermittent claudication—a condition where poor blood flow causes severe leg pain during exercise.
## NAD and NADP: The Energy Coenzymes
Beyond blood flow, IHN serves as a highly effective, slow-drip source of Vitamin B3 for general health. All tissues in the body convert absorbed niacin into its main metabolically active form: nicotinamide adenine dinucleotide (NAD+).
According to the NIH Office of Dietary Supplements, more than 400 enzymes require NAD to catalyze reactions in the body—more than for any other vitamin-derived coenzyme. NAD is primarily involved in catabolic reactions that transfer the potential energy in carbohydrates, fats, and proteins into ATP, the primary energy currency of the cell. It is also converted into NADP, which enables anabolic reactions like the synthesis of fatty acids and plays a critical role in maintaining cellular antioxidant function. By providing a steady supply of nicotinic acid, IHN ensures the body has the raw materials necessary to maintain optimal NAD+ levels for daily energy metabolism.
## Dosage, Safety, and Label Literacy
The Recommended Daily Allowance (RDA) for Vitamin B3 is 16 mg for adult men and 14 mg for adult women. However, therapeutic doses of Inositol Hexanicotinate found in supplements typically range from 500 mg to 1,000 mg. Because it is metabolized so slowly, it is generally considered very safe and well-tolerated, avoiding both the flush of immediate-release niacin and the liver toxicity associated with sustained-release (SR) niacin.
When shopping for supplements, label literacy is crucial. Many products simply list 'Niacin' on the front, but checking the supplement facts panel will reveal 'Niacin (as Inositol Hexanicotinate)'. Remember: if you are buying this for general energy, NAD+ support, or peripheral blood flow (cold hands/feet), IHN is an excellent choice. If you are buying it to lower your LDL cholesterol, you are wasting your money. Always align the specific chemical form of the vitamin with your specific health goals.